Carl Zeiss Meditec stock

AFX · Xetra · EUR

Compare Carl Zeiss Meditec
€31.90Change from previous close: −1.12%Absolute change: −€0.36

Close · November 20, 2026

Price history

−24.98% over the period

1 year: from €42.52 (November 20, 2025) to €31.90 (November 20, 2026), −24.98%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026€31.90
October 30, 2026€34.98
September 30, 2026€31.28
August 31, 2026€32.14
July 31, 2026€30.50
June 30, 2026€26.62
May 29, 2026€25.88
April 30, 2026€26.48
March 31, 2026€24.20
February 27, 2026€27.12
January 30, 2026€28.00
December 30, 2025€40.00
November 28, 2025€44.54
November 20, 2025€42.52

At a glance

  • The company

    Develops medical technology products for ophthalmology and microsurgery, including diagnostic devices, surgical equipment, and digital solutions

  • Latest results

    Quarter to June 30, 2026 · EPS €0.54 (estimate €0.41)

TickerLandia's take on Carl Zeiss Meditec

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low€22.62
52-wk high€46.54

−31.46% from the 52-week high

Analysts · 15 analysts

Average target€26.86−15.80% vs. price

Buy 0 · Hold 8 · Sell 7 · Sell

TickerLandia Fingerprint: Carl Zeiss Meditec

Compared with similar companies: low profitability and low price.

Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Carl Zeiss Meditec is cheaper than in the past and cheaper than similar companies

On the latest fiscal year's earnings (2025), Carl Zeiss Meditec's P/E today is 19.8, below the median of its last 10 fiscal years (34.0; between 25.5 and 78.9 from 2016 to 2025). Carl Zeiss Meditec's P/E (trailing 12 months): 23.3, −7% against the median of a group of 9 similar companies (25.1).

P/E compared with its history

Compared with 9 similar companies

Carl Zeiss Meditec's metrics compared with similar companies
MetricCarl Zeiss MeditecPosition in the groupBand
P/E (trailing 12 months)23.3Middle
Forward P/E21.9Middle
Operating margin7.2%Middle
ROE4.5%Low
Debt/equity0.28Middle

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Carl Zeiss Meditec. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

€562.72M

Latest quarter · Q2 2026

Net income

€55.03M

Latest quarter · Q2 2026

Quarterly net margin

9.8%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
€2.79B
P/E
23.3
EPS
€1.37
Volume
167.86K
Daily trading
€4.82M
Dividend yield
1.72%
Last ex-dividend on March 27, 2026

How Carl Zeiss Meditec is changing

All results
  • Revenue grew 10.8% a year on average over the last 5 years

  • Operating margin fell from 20.9% to 10.0%

  • Free cash flow equal to 85% of net income

Returns

Carl Zeiss Meditec returns with dividends

€1,000 invested in Carl Zeiss Meditec 5 years ago, on November 22, 2021, would be worth €184 today with dividends reinvested: −81.60% in total, −28.75% per year. On price alone it would be €174 (−82.59%).

PeriodCarl Zeiss MeditecDAX€1,000 becomes
1 month−5.51%−1.98%€945
6 months+24.32%+0.26%€1,243
Year to date−20.25%+1.28%€798
1 year−23.28%+6.55%€767
3 years−61.48%+55.98%€385
5 years−81.60%+53.90%€184
10 years+7.74%+132.12%€1,077

Over the last 6 months it has done better than 56% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. DAX: with dividends. Calculate your investment

The chart in detail

Carl Zeiss Meditec: technical analysis

Carl Zeiss Meditec shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 84.0% below its all-time closing high (€199.05, September 21, 2021).

Trend
No clear trend
RSI (14 sessions)
36
Between 30 and 70
vs 200-session average
+10.87%

Active signals

  • Close below the low of the previous 20 sessions.

Support and resistance

Price areas where Carl Zeiss Meditec has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance€36.27+13.70%2 touches, last on November 5, 2026
  2. Resistance€33.03+3.54%2 touches, last on September 1, 2026
  3. Resistance€31.96+0.19%3 touches, last on September 28, 2026
  4. Last price€31.90
  5. Support€28.74−9.92%6 touches, last on October 5, 2026
  6. Support€27.26−14.55%7 touches, last on August 11, 2026
  7. Support€25.25−20.86%3 touches, last on April 30, 2026

Volatility and risk

Over the last year it has moved little with the DAX.

Beta (1 year) vs DAX
0.39
Volatility (60 sessions, annualised)
30.9%
Largest fall in the last year
−49.20%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Carl Zeiss Meditec: seasonality

Average monthly price change over 27 years

+1.8%Jan+0.4%Feb+0.7%Mar+0.2%Apr+0.6%May−1.4%Jun+2.0%Jul−2.9%Aug−0.2%Sep+1.9%Oct+4.6%Nov+0.8%Dec

Over the last 27 years, the strongest month for Carl Zeiss Meditec has been November: +4.58% on average, positive in 21 years out of 26. The weakest has been August: −2.88% on average, positive in 11 years out of 27.

Show chart data
MonthAverageMedianPositive years
January+1.84%+0.22%13 of 26
February+0.37%−0.17%12 of 26
March+0.69%+0.54%14 of 26
April+0.16%−0.83%13 of 27
May+0.58%−0.99%12 of 27
June−1.36%−1.18%13 of 27
July+2.02%+0.81%15 of 27
August−2.88%−2.35%11 of 27
September−0.18%−0.86%12 of 27
October+1.91%+2.69%15 of 27
November+4.58%+4.06%21 of 26
December+0.82%+2.05%16 of 26

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Carl Zeiss Meditec and its competitors

With revenue of EUR 2.2 billion in the fiscal year ended September 2025, Carl Zeiss Meditec AG is a medical technology company whose activities are split between two segments, Ophthalmology and Microsurgery. The Ophthalmology business supplies instruments for diagnosing and treating chronic eye diseases, from slit lamps and optical coherence tomography systems to surgical microscopes, intraocular lenses and laser eye surgery equipment. The Microsurgery segment offers surgical visualization, intraoperative radiotherapy and pathology, special instruments and digital solutions for minimally invasive procedures.

Headquarters
Jena, Germany
Employees
5,784
Founded
1846
Chief executive
Andreas Pecher
Carl Zeiss Meditec and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Carl Zeiss MeditecAFX$3.07B7.2%23.3+24.32%
OttobockOBCK$2.68B18.7%19.0−31.33%
Tecan GroupTECN$3.58B4.9%—+64.44%
SCHOTT Pharma1SXP$3.74B16.4%25.1+34.04%
Fielmann GroupFIE$3.93B13.7%16.4−3.95%
AddLifeALIF.B$2.11B8.9%33.5+17.73%

Same industry or related industries, similar size. Compare Carl Zeiss Meditec with its competitors · Full profile